Using in vivo CRISPR screens, a Mount Sinai Hospital research team has discovered that many cases of head and neck squamous cell carcinoma (HNSCC) are driven by rare mutations in the NOTCH tumor suppressor signaling pathway.
Using in vivo CRISPR screens, a Mount Sinai Hospital research team has discovered that many cases of head and neck squamous cell carcinoma (HNSCC) are driven by rare mutations in the NOTCH tumor suppressor signaling pathway.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.